TY - JOUR
T1 - Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease
T2 - The cosaecopd ers task force study protocol
AU - Mathioudakis, Alexander G.
AU - Abroug, Fekri
AU - Agusti, Alvar
AU - Bakke, Per
AU - Bartziokas, Konstantinos
AU - Beghe, Bianca
AU - Bikov, Andras
AU - Bradbury, Thomas
AU - Brusselle, Guy
AU - Cadus, Cordula
AU - Coleman, Courtney
AU - Contoli, Marco
AU - Corlateanu, Alexandru
AU - Corlateanu, Olga
AU - Criner, Gerard
AU - Csoma, Balazs
AU - Emelyanov, Alexander
AU - Faner, Rosa
AU - Romero, Gustavo Fernandez
AU - Hammouda, Zeineb
AU - Horváth, Peter
AU - Huerta, Arturo Garcia
AU - Jacobs, Michael
AU - Jenkins, Christine
AU - Joos, Guy
AU - Kharevich, Olga
AU - Kostikas, Konstantinos
AU - Lapteva, Elena
AU - Lazar, Zsofia
AU - Leuppi, Joerg D.
AU - Liddle, Carol
AU - López-Giraldo, Alejandra
AU - McDonald, Vanessa M.
AU - Nielsen, Rune
AU - Papi, Alberto
AU - Saraiva, Isabel
AU - Sergeeva, Galina
AU - Sioutkou, Agni
AU - Sivapalan, Pradeesh
AU - Stovold, Elizabeth
AU - Wang, Hao
AU - Wen, Fuqiang
AU - Yorke, Janelle
AU - Williamson, Paula R.
AU - Vestbo, Jørgen
AU - Jensen, Jens Ulrik
N1 - Publisher Copyright:
© ERS 2020.
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Randomised controlled trials (RCTs) on the management of COPD exacerbations evaluate heterogeneous outcomes, often omitting those that are clinically important and patient relevant. This limits their usability and comparability. A core outcome set (COS) is a consensus-based minimum set of clinically important outcomes that should be evaluated in all RCTs in specific areas of health care. We present the study protocol of the COS-AECOPD ERS Task Force, aiming to develop a COS for COPD exacerbation management, that could remedy these limitations. For the development of this COS we follow standard methodology recommended by the COMET initiative. A comprehensive list of outcomes is assembled through a methodological systematic review of the outcomes reported in relevant RCTs. Qualitative research with patients with COPD will also be conducted, aiming to identify additional outcomes that may be important to patients, but are not currently addressed in clinical research studies. Prioritisation of the core outcomes will be facilitated through an extensive, multi-stakeholder Delphi survey with a global reach. Selection will be finalised in an international, multi-stakeholder meeting. For every core outcome, we will recommend a specific measurement instrument and standardised time points for evaluation. Selection of instruments will be based on evidence-informed consensus. Our work will improve the quality, usability and comparability of future RCTs on the management of COPD exacerbations and, ultimately, the care of patients with COPD. Multi-stakeholder engagement and societal support by the European Respiratory Society will raise awareness and promote implementation of the COS.
AB - Randomised controlled trials (RCTs) on the management of COPD exacerbations evaluate heterogeneous outcomes, often omitting those that are clinically important and patient relevant. This limits their usability and comparability. A core outcome set (COS) is a consensus-based minimum set of clinically important outcomes that should be evaluated in all RCTs in specific areas of health care. We present the study protocol of the COS-AECOPD ERS Task Force, aiming to develop a COS for COPD exacerbation management, that could remedy these limitations. For the development of this COS we follow standard methodology recommended by the COMET initiative. A comprehensive list of outcomes is assembled through a methodological systematic review of the outcomes reported in relevant RCTs. Qualitative research with patients with COPD will also be conducted, aiming to identify additional outcomes that may be important to patients, but are not currently addressed in clinical research studies. Prioritisation of the core outcomes will be facilitated through an extensive, multi-stakeholder Delphi survey with a global reach. Selection will be finalised in an international, multi-stakeholder meeting. For every core outcome, we will recommend a specific measurement instrument and standardised time points for evaluation. Selection of instruments will be based on evidence-informed consensus. Our work will improve the quality, usability and comparability of future RCTs on the management of COPD exacerbations and, ultimately, the care of patients with COPD. Multi-stakeholder engagement and societal support by the European Respiratory Society will raise awareness and promote implementation of the COS.
UR - http://www.scopus.com/inward/record.url?scp=85097927581&partnerID=8YFLogxK
U2 - 10.1183/23120541.00193-2020
DO - 10.1183/23120541.00193-2020
M3 - Journal article
AN - SCOPUS:85097927581
SN - 2312-0541
VL - 6
SP - 1
EP - 10
JO - ERJ Open Research
JF - ERJ Open Research
IS - 3
M1 - 00193-2020
ER -